Delivery Order SPE2DB22D3016-SPE2DB25FAUT6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,021.07 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Mirtazapine 7.5 mg tablets (30-count units). This is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order operates under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Mirtazapine 7.5 mg tablets in quantities of 500 units, valued at $5,732.50 under a firm fixed-price contract. This delivery order was competitively awarded with no set-aside designation and is scheduled for completion by September 9, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on June 16, 2025, for the supply of Mirtazapine 7.5 mg tablets in quantities of 30 per unit. The contract, which is a non-set-aside, competitively awarded delivery order with firm fixed pricing, carries a ceiling value of $1,149.60 and an ultimate completion date of June 17, 2025. This delivery order is a child contract executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,107.52 delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of 500 tablets of Mirtazapine 7.5 mg. This is a non-set-aside, firm fixed-price delivery order with an ultimate completion date of September 30, 2025, performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's existing Indefinite Delivery Contract vehicle with DLA Troop Support Medical....
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Mirtazapine 7.5 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $10,216.91 and an ultimate completion date of September 5, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 tablets of Mirtazapine 7.5 mg, valued at $1,496.18 with a firm fixed price arrangement. The contract, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a competitive award with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of 1,000 tablets of Mirtazapine 30 mg, a generic antidepressant medication commonly used in military and veteran healthcare settings. This non-competitive delivery order, valued at $3,425.77 with firm fixed pricing, is scheduled for completion by November 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a...
- The Defense Logistics Agency awarded a $2,402.57 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Mirtazapine 15 mg, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order was issued under a non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,853.86 by the Defense Logistics Agency's Medical Supply Chain on July 22, 2025, for the supply of Mirtazapine 7.5 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 4, 2025, for the supply of Mirtazapine 7.5 mg tablets in quantities of 30. This firm fixed price delivery order, valued at $2,366.71, represents a non-competitive award under a larger indefinite delivery contract vehicle. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The contract is...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FAUT6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Mirtazapine 7.5 mg tablets in quantities of 500 units, with a ceiling value of $4,537.30. This firm fixed price delivery order, with an ultimate completion date of April 25, 2025, represents a non-competitive award and will be performed at the contractor's Conshohocken, Pennsylvania location. The order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle valued through December 2026 that supports military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through its extensive portfolio of pharmaceutical products and medical supplies. The company's federal contracting demonstrates significant capability in fulfilling diverse medication requirements across multiple therapeutic domains through competitively awarded delivery orders under DLA's umbrella contracts. This particular delivery order for mirtazapine, an antidepressant medication, exemplifies the routine pharmaceutical supply chain support the contractor provides to military and federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 4/24/25 |